Loading…
Secretion of interleukin-6 (IL-6)by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha
We studied IL-6 gene expression in human monocytes stimulated by muramyl dipeptide (MDP), a synthetic immunomodulator derived from mycobacterial cell walls. In control monocytes, two IL-6 transcripts of 3.4 kb and 1.6 kb were easily detected at 2.5 hr of culture and remained stable until 18 hr. In M...
Saved in:
Published in: | Immunology 1990, Vol.69 (1), p.52-56 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 56 |
container_issue | 1 |
container_start_page | 52 |
container_title | Immunology |
container_volume | 69 |
creator | SANCEAU, J FALCOFF, R BERANGER, F CARTER, D. B WIETZERBIN, J |
description | We studied IL-6 gene expression in human monocytes stimulated by muramyl dipeptide (MDP), a synthetic immunomodulator derived from mycobacterial cell walls. In control monocytes, two IL-6 transcripts of 3.4 kb and 1.6 kb were easily detected at 2.5 hr of culture and remained stable until 18 hr. In MDP-treated monocytes, three IL-6 RNA species displayed different kinetics of accumulation: a 3.4 kb RNA whose expression already reached its maximum after 2.5 hr exposure to MDP; a 1.6 kb RNA whose expression peaked at 5 hr; and a new RNA species of 1.4 kb which was transiently induced in early time of cell stimulation. TNF-alpha co-operated with MDP to increase IL-6 gene expression and secretion of biological active protein (measured by the hybridoma plasmacytoma growth factor assay). MDP exhibits a broad spectrum of immunomodulation properties such as adjuvant activity, enhancement of macrophage cytotoxicity against tumour and induction of non-specific resistance to intracellular agents. The results reported here suggest that these properties might be linked to the stimulation by MDP of genes coding for key cytokines such as IL-6, TNF and IL-1. |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1385719</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15482361</sourcerecordid><originalsourceid>FETCH-LOGICAL-g376t-803ed6212e084e778a7197d55f88fa88dff0582da91996ecdb9a8d30a108ee383</originalsourceid><addsrcrecordid>eNqNkU2LFDEQhhtR1tnVnyDkIOIeGpLOJqm-CLKsujDgQT03NZ3qnWg-2nwI8-9tcFj05qkonpenXqgn3U5IrfpBafO023Euxn4Arp53l6V831bJlbroLoQeuTBm19UvNGeqLkWWFuZipeyp_XCx1-zt_b7X14cTO7aAkYUU03yqVFipLjSPlSzbaGgZw8kz61Zaq7PEMFpWW0gts7jpU3GFLTjXlBn69YgvumcL-kIvz_Oq-_bh7uvtp37_-eP97ft9_yCNrj1wSVYPYiAON2QMoBGjsUotAAsC2GXhCgaLoxhHTbM9jAhWchQciCTIq-7dH-_aDoHsTLFm9NOaXcB8mhK66V8S3XF6SL8mIUFttzbBm7Mgp5-NSp2CKzN5j5FSK5NQGoQS8B_BGxikFlvw1d-VHrucH7Lx12eOZUa_ZIyzK48xDUYNSsrfydqXQA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15482361</pqid></control><display><type>article</type><title>Secretion of interleukin-6 (IL-6)by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha</title><source>PubMed Central</source><creator>SANCEAU, J ; FALCOFF, R ; BERANGER, F ; CARTER, D. B ; WIETZERBIN, J</creator><creatorcontrib>SANCEAU, J ; FALCOFF, R ; BERANGER, F ; CARTER, D. B ; WIETZERBIN, J</creatorcontrib><description>We studied IL-6 gene expression in human monocytes stimulated by muramyl dipeptide (MDP), a synthetic immunomodulator derived from mycobacterial cell walls. In control monocytes, two IL-6 transcripts of 3.4 kb and 1.6 kb were easily detected at 2.5 hr of culture and remained stable until 18 hr. In MDP-treated monocytes, three IL-6 RNA species displayed different kinetics of accumulation: a 3.4 kb RNA whose expression already reached its maximum after 2.5 hr exposure to MDP; a 1.6 kb RNA whose expression peaked at 5 hr; and a new RNA species of 1.4 kb which was transiently induced in early time of cell stimulation. TNF-alpha co-operated with MDP to increase IL-6 gene expression and secretion of biological active protein (measured by the hybridoma plasmacytoma growth factor assay). MDP exhibits a broad spectrum of immunomodulation properties such as adjuvant activity, enhancement of macrophage cytotoxicity against tumour and induction of non-specific resistance to intracellular agents. The results reported here suggest that these properties might be linked to the stimulation by MDP of genes coding for key cytokines such as IL-6, TNF and IL-1.</description><identifier>ISSN: 0019-2805</identifier><identifier>EISSN: 1365-2567</identifier><identifier>PMID: 1690177</identifier><identifier>CODEN: IMMUAM</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>Acetylmuramyl-Alanyl-Isoglutamine - pharmacology ; Analysis of the immune response. Humoral and cellular immunity ; Biological and medical sciences ; Blotting, Northern ; Cells, Cultured ; Drug Synergism ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Gene Expression - immunology ; Humans ; Immunobiology ; Interleukin-6 - analysis ; Interleukin-6 - genetics ; Lymphokines, interleukins ( function, expression) ; Monocytes - drug effects ; Monocytes - immunology ; Regulatory factors and their cellular receptors ; RNA - analysis ; Tumor Necrosis Factor-alpha - pharmacology</subject><ispartof>Immunology, 1990, Vol.69 (1), p.52-56</ispartof><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1385719/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1385719/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,4010,53772,53774</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6875253$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1690177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SANCEAU, J</creatorcontrib><creatorcontrib>FALCOFF, R</creatorcontrib><creatorcontrib>BERANGER, F</creatorcontrib><creatorcontrib>CARTER, D. B</creatorcontrib><creatorcontrib>WIETZERBIN, J</creatorcontrib><title>Secretion of interleukin-6 (IL-6)by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha</title><title>Immunology</title><addtitle>Immunology</addtitle><description>We studied IL-6 gene expression in human monocytes stimulated by muramyl dipeptide (MDP), a synthetic immunomodulator derived from mycobacterial cell walls. In control monocytes, two IL-6 transcripts of 3.4 kb and 1.6 kb were easily detected at 2.5 hr of culture and remained stable until 18 hr. In MDP-treated monocytes, three IL-6 RNA species displayed different kinetics of accumulation: a 3.4 kb RNA whose expression already reached its maximum after 2.5 hr exposure to MDP; a 1.6 kb RNA whose expression peaked at 5 hr; and a new RNA species of 1.4 kb which was transiently induced in early time of cell stimulation. TNF-alpha co-operated with MDP to increase IL-6 gene expression and secretion of biological active protein (measured by the hybridoma plasmacytoma growth factor assay). MDP exhibits a broad spectrum of immunomodulation properties such as adjuvant activity, enhancement of macrophage cytotoxicity against tumour and induction of non-specific resistance to intracellular agents. The results reported here suggest that these properties might be linked to the stimulation by MDP of genes coding for key cytokines such as IL-6, TNF and IL-1.</description><subject>Acetylmuramyl-Alanyl-Isoglutamine - pharmacology</subject><subject>Analysis of the immune response. Humoral and cellular immunity</subject><subject>Biological and medical sciences</subject><subject>Blotting, Northern</subject><subject>Cells, Cultured</subject><subject>Drug Synergism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Gene Expression - immunology</subject><subject>Humans</subject><subject>Immunobiology</subject><subject>Interleukin-6 - analysis</subject><subject>Interleukin-6 - genetics</subject><subject>Lymphokines, interleukins ( function, expression)</subject><subject>Monocytes - drug effects</subject><subject>Monocytes - immunology</subject><subject>Regulatory factors and their cellular receptors</subject><subject>RNA - analysis</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><issn>0019-2805</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNqNkU2LFDEQhhtR1tnVnyDkIOIeGpLOJqm-CLKsujDgQT03NZ3qnWg-2nwI8-9tcFj05qkonpenXqgn3U5IrfpBafO023Euxn4Arp53l6V831bJlbroLoQeuTBm19UvNGeqLkWWFuZipeyp_XCx1-zt_b7X14cTO7aAkYUU03yqVFipLjSPlSzbaGgZw8kz61Zaq7PEMFpWW0gts7jpU3GFLTjXlBn69YgvumcL-kIvz_Oq-_bh7uvtp37_-eP97ft9_yCNrj1wSVYPYiAON2QMoBGjsUotAAsC2GXhCgaLoxhHTbM9jAhWchQciCTIq-7dH-_aDoHsTLFm9NOaXcB8mhK66V8S3XF6SL8mIUFttzbBm7Mgp5-NSp2CKzN5j5FSK5NQGoQS8B_BGxikFlvw1d-VHrucH7Lx12eOZUa_ZIyzK48xDUYNSsrfydqXQA</recordid><startdate>1990</startdate><enddate>1990</enddate><creator>SANCEAU, J</creator><creator>FALCOFF, R</creator><creator>BERANGER, F</creator><creator>CARTER, D. B</creator><creator>WIETZERBIN, J</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>1990</creationdate><title>Secretion of interleukin-6 (IL-6)by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha</title><author>SANCEAU, J ; FALCOFF, R ; BERANGER, F ; CARTER, D. B ; WIETZERBIN, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g376t-803ed6212e084e778a7197d55f88fa88dff0582da91996ecdb9a8d30a108ee383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Acetylmuramyl-Alanyl-Isoglutamine - pharmacology</topic><topic>Analysis of the immune response. Humoral and cellular immunity</topic><topic>Biological and medical sciences</topic><topic>Blotting, Northern</topic><topic>Cells, Cultured</topic><topic>Drug Synergism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Gene Expression - immunology</topic><topic>Humans</topic><topic>Immunobiology</topic><topic>Interleukin-6 - analysis</topic><topic>Interleukin-6 - genetics</topic><topic>Lymphokines, interleukins ( function, expression)</topic><topic>Monocytes - drug effects</topic><topic>Monocytes - immunology</topic><topic>Regulatory factors and their cellular receptors</topic><topic>RNA - analysis</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SANCEAU, J</creatorcontrib><creatorcontrib>FALCOFF, R</creatorcontrib><creatorcontrib>BERANGER, F</creatorcontrib><creatorcontrib>CARTER, D. B</creatorcontrib><creatorcontrib>WIETZERBIN, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SANCEAU, J</au><au>FALCOFF, R</au><au>BERANGER, F</au><au>CARTER, D. B</au><au>WIETZERBIN, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Secretion of interleukin-6 (IL-6)by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha</atitle><jtitle>Immunology</jtitle><addtitle>Immunology</addtitle><date>1990</date><risdate>1990</risdate><volume>69</volume><issue>1</issue><spage>52</spage><epage>56</epage><pages>52-56</pages><issn>0019-2805</issn><eissn>1365-2567</eissn><coden>IMMUAM</coden><abstract>We studied IL-6 gene expression in human monocytes stimulated by muramyl dipeptide (MDP), a synthetic immunomodulator derived from mycobacterial cell walls. In control monocytes, two IL-6 transcripts of 3.4 kb and 1.6 kb were easily detected at 2.5 hr of culture and remained stable until 18 hr. In MDP-treated monocytes, three IL-6 RNA species displayed different kinetics of accumulation: a 3.4 kb RNA whose expression already reached its maximum after 2.5 hr exposure to MDP; a 1.6 kb RNA whose expression peaked at 5 hr; and a new RNA species of 1.4 kb which was transiently induced in early time of cell stimulation. TNF-alpha co-operated with MDP to increase IL-6 gene expression and secretion of biological active protein (measured by the hybridoma plasmacytoma growth factor assay). MDP exhibits a broad spectrum of immunomodulation properties such as adjuvant activity, enhancement of macrophage cytotoxicity against tumour and induction of non-specific resistance to intracellular agents. The results reported here suggest that these properties might be linked to the stimulation by MDP of genes coding for key cytokines such as IL-6, TNF and IL-1.</abstract><cop>Oxford</cop><pub>Blackwell</pub><pmid>1690177</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0019-2805 |
ispartof | Immunology, 1990, Vol.69 (1), p.52-56 |
issn | 0019-2805 1365-2567 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1385719 |
source | PubMed Central |
subjects | Acetylmuramyl-Alanyl-Isoglutamine - pharmacology Analysis of the immune response. Humoral and cellular immunity Biological and medical sciences Blotting, Northern Cells, Cultured Drug Synergism Fundamental and applied biological sciences. Psychology Fundamental immunology Gene Expression - immunology Humans Immunobiology Interleukin-6 - analysis Interleukin-6 - genetics Lymphokines, interleukins ( function, expression) Monocytes - drug effects Monocytes - immunology Regulatory factors and their cellular receptors RNA - analysis Tumor Necrosis Factor-alpha - pharmacology |
title | Secretion of interleukin-6 (IL-6)by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A05%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Secretion%20of%20interleukin-6%20(IL-6)by%20human%20monocytes%20stimulated%20by%20muramyl%20dipeptide%20and%20tumour%20necrosis%20factor%20alpha&rft.jtitle=Immunology&rft.au=SANCEAU,%20J&rft.date=1990&rft.volume=69&rft.issue=1&rft.spage=52&rft.epage=56&rft.pages=52-56&rft.issn=0019-2805&rft.eissn=1365-2567&rft.coden=IMMUAM&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E15482361%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g376t-803ed6212e084e778a7197d55f88fa88dff0582da91996ecdb9a8d30a108ee383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15482361&rft_id=info:pmid/1690177&rfr_iscdi=true |